Efficacy of omalizumab in the therapy of severe persistent bronchial asthma Exclusive - compliance and utilisation investigation under real-life conditions

被引:0
|
作者
Schumann, C. [1 ]
Merk, T. [1 ]
Hundack, L. [1 ]
Stoiber, K. [1 ]
Thielen, A. [2 ]
Kroegel, C. [3 ]
Hus-Marp, J. [1 ]
机构
[1] Univ Klin Ulm, Klin Innere Med 2, Ulm, Germany
[2] Novartis, Nurnberg, Germany
[3] Univ Klin Jena, Jena, Germany
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
787
引用
收藏
页码:308 / 308
页数:1
相关论文
共 50 条
  • [31] Real-life Evidence on the Treatment Response of Tezepelumab in severe Bronchial Asthma in Germany
    Biener, L.
    Hackl, C.
    Hinze, C.
    Korn, S.
    Fisser, C.
    Biener, A.
    Suhling, H.
    Skowasch, D.
    Milger-Kneidinger, K.
    PNEUMOLOGIE, 2024, 78 : S8 - S8
  • [32] An Audit into Efficacy of Omalizumab Therapy in Patients with Severe Persistent Allergic Asthma at Tallaght Hospital
    Subramaniam, A.
    Al-Alawi, M.
    Hamad, S.
    O'Callaghan, J.
    Lane, S. J.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2012, 181 : S405 - S405
  • [33] Real-Life Benefit of Omalizumab in Improving Control of Bronchial Asthma During COVID-19 Pandemic
    Leru, Polliana Mihaela
    Anton, Vlad Florin
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)
  • [34] COMPLIANCE AND ADHERENCE TO OMALIZUMAB THERAPY AND CORRELATION TO RESPONSE TO THERAPY IN A REAL-LIFE CLINICAL SETTING: A RETROSPECTIVE ANALYSIS
    Singh, H.
    Kaur, Y.
    Diaz, J. D.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 115 (05) : A58 - A58
  • [35] Real-life study on the efficacy of tiotropium bromide in pediatric severe asthma
    Murata, Juliana
    Drobrzenski, Jessica
    Ferreira, Caroline
    Vital, Nathalia
    Dias, Renata
    Sole, Dirceu
    Rosario, Nelson
    Pastorino, Antonio
    Chong Neto, Herberto
    Wandalsen, Gustavo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB28 - AB28
  • [36] Real-Life Effectiveness of Benralizumab, Mepolizumab and Omalizumab in Severe Allergic Asthma Associated with Nasal Polyps
    Tiotiu, Angelica
    Mendez-Brea, Paula
    Ioan, Iulia
    Romero-Fernandez, Rodrigo
    Oster, Jean Philippe
    Hoang, Thi-cam-tu
    Roux, Pauline
    Ochoa-Gutierrez, Diana Carolina
    Bonniaud, Philippe
    de Blay, Frederic
    Gonzalez-Barcala, Francisco-Javier
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2023, 64 (02) : 179 - 192
  • [37] Omalizumab reduces oral corticosteroid use in patients with severe allergic asthma: Real-life data
    Molimard, M.
    Buhl, R.
    Niven, R.
    Le Gros, V.
    Thielen, A.
    Thirlwell, J.
    Maykut, R.
    Peachey, G.
    RESPIRATORY MEDICINE, 2010, 104 (09) : 1381 - 1385
  • [38] Omalizumab Reduces Corticosteroid Use in Patients with Severe Allergic Asthma: Real-Life Experience in Israel
    Rottem, Menachem
    JOURNAL OF ASTHMA, 2012, 49 (01) : 78 - 82
  • [39] Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria
    Hew, M.
    Gillman, A.
    Sutherland, M.
    Wark, P.
    Bowden, J.
    Guo, M.
    Reddel, H. K.
    Jenkins, C.
    Marks, G. B.
    Thien, F.
    Rimmer, J.
    Katsoulotos, G. P.
    Cook, M.
    Yang, I.
    Katelaris, C.
    Bowler, S.
    Langton, D.
    Wright, C.
    Bint, M.
    Yozghatlian, V.
    Burgess, S.
    Sivakumaran, P.
    Yan, K. Y.
    Kritikos, V.
    Peters, M.
    Baraket, M.
    Aminazad, A.
    Robinson, P.
    Jaffe, A.
    Powell, H.
    Upham, J. W.
    McDonald, V. M.
    Gibson, P. G.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2016, 46 (11): : 1407 - 1415
  • [40] 'Real-life' effectiveness studies of omalizumab in adult patients with severe allergic asthma: systematic review
    Abraham, I.
    Alhossan, A.
    Lee, C. S.
    Kutbi, H.
    MacDonald, K.
    ALLERGY, 2016, 71 (05) : 593 - 610